SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories completes investment in SIA ZIM Laboratories

19 Jun 2025 Evaluate

Zim Laboratories has completed the process of investment of Euro 3,00,000 in the equity shares of SIA ZIM Laboratories. Post investment, the shareholding of the company remains at 100% of the total share capital of SIA ZIM Laboratories.

Earlier, the board of directors of the company in their meeting held on March 28, 2025 had approved the investment in SIA ZIM Laboratories, wholly owned subsidiary of the company. 

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.

Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×